| Safety Study of Riluzole to Treat Post-traumatic Stress Disorder (PTSD) (NCT02155829) | Uniformed Services University of the Health Sciences | 2013-07-01 |
| Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia (NCT01909466) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2013-07-01 |
| Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia (NCT01919385) | Animas Corporation | 2013-07-01 |
| Spinal Cord Neuromodulation for Spinal Cord Injury (NCT02313194) | University of California, Los Angeles | 2013-07-01 |
| Safety Study of Gintuit™ in Subjects Requiring Socket Grafting (NCT01929954) | Organogenesis | 2013-07-01 |
| Phase 1/II, Safety and Immunogenicity Study of AERAS-404 in BCG-Primed Infants (NCT01861730) | Aeras | 2013-07-01 |
| Autologous Redirected RNA Meso CAR T Cells for Pancreatic Cancer (NCT01897415) | University of Pennsylvania | 2013-07-01 |
| PKPD Study of Ticagrelor and Prasugrel in Healthy Korean Males (NCT01876797) | Asan Medical Center | 2013-07-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamic of AZD1722 in Healthy Male and Female Japanese Subjects (NCT02176252) | Ardelyx | 2013-07-01 |
| PK and PD Study of Natalizumab in Pediatric Subjects With RRMS (NCT01884935) | Biogen | 2013-07-01 |
| Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections (NCT01893346) | Pfizer | 2013-07-01 |
| Ponatinib for FLT3-ITD Acute Myelogenous Leukemia (NCT02428543) | Versailles Hospital | 2013-07-01 |
| A Study of Evacetrapib and Rifampin in Healthy Participants (NCT01908582) | Eli Lilly and Company | 2013-07-01 |
| Study of Adoptive Immunotherapy With Donor-derived CMV-specific T Cells for Recipients of Allo-HSCT (NCT02988258) | University College, London | 2013-07-01 |
| To Assess the Pharmacokinetics and Safety of Single Doses of JNJ-54452840 in Healthy Japanese and Caucasian Participants (NCT01809353) | Janssen Research & Development, LLC | 2013-07-01 |
| Multiple Antigen Specific Cell Therapy (MASCT) for Hepatocellular Carcinoma(HCC) Patients After Radical Resection or Radio Frequency Ablation(RFA). (NCT02026362) | HRYZ Biotech Co. | 2013-07-01 |
| Pilot Study of the Safety of a Daily Ethanol Lock for Urinary Catheters in Critically Ill Children (NCT01865708) | Children's Healthcare of Atlanta | 2013-07-01 |
| Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia (NCT01900522) | Takeda | 2013-07-01 |
| A Study of Evacetrapib and Digoxin in Healthy Participants (NCT01897493) | Eli Lilly and Company | 2013-07-01 |
| Effects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of Edoxaban (NCT01826266) | Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. | 2013-07-01 |
| Cell Therapy by Bone Marrow-derived Mononuclear Cells (BMC) for Large Bone Defect Repair: Phase-I Clinical Trial (NCT02153372) | Goethe University | 2013-07-01 |
| Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy (NCT01843387) | Mesoblast, Ltd. | 2013-07-01 |
| Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of NBI-98854 in Healthy Subjects (NCT01910480) | Neurocrine Biosciences | 2013-07-01 |
| A Single and Multiple Oral Dose Study and a Treatment Schedule-finding Study in Non-elderly, Healthy Subjects (NCT02500953) | Astellas Pharma Inc | 2013-07-01 |
| Safety and Efficacy of Melflufen and Dexamethasone in Relapsed and/or Relapsed-Refractory Multiple Myeloma Patients (NCT01897714) | Oncopeptides AB | 2013-07-01 |
| Gemcitabine and Pulse Dose Erlotinib in Second Line Treatment of Advanced Pancreatic Cancer (NCT02154737) | Tony Reid, M.D., Ph.D. | 2013-07-01 |
| Lesinurad Interaction Study With Ranitidine (NCT01908257) | Ardea Biosciences, Inc. | 2013-07-01 |
| Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05% (NCT01892137) | LEO Pharma | 2013-07-01 |
| Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies (NCT01905813) | Incyte Corporation | 2013-06-30 |
| Safety and Tolerability of BI 409306 in Patients With Schizophrenia (NCT01892384) | Boehringer Ingelheim | 2013-06-28 |
| A Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological Malignancies (NCT01830010) | Novartis Pharmaceuticals | 2013-06-28 |
| A Safety and Pharmacokinetic Study of TAK-228 in Combination With TAK-117 in Adult Participants With Advanced Nonhematologic Malignancies (NCT01899053) | Millennium Pharmaceuticals, Inc. | 2013-06-28 |
| First-in-man Dose Escalation Study of BAY1179470 in Patients With Advanced, Refractory Solid Tumors (NCT01881217) | Bayer | 2013-06-28 |
| Evaluation of Two Radioactive Chemicals to Image mGluR5 Receptors in Brain (NCT01896843) | National Institute of Mental Health (NIMH) | 2013-06-27 |
| Use of Minocycline in Intracerebral Hemorrhage (NCT03040128) | University of Tennessee | 2013-06-27 |
| Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis (NCT01783756) | Jonsson Comprehensive Cancer Center | 2013-06-26 |
| Effects of Interrupting Sedentary Behavior on Metabolic and Cognitive Outcomes in Children (NCT01888939) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2013-06-26 |
| Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular Lymphoma (NCT01829568) | National Cancer Institute (NCI) | 2013-06-26 |
| Safety, Tolerability and Pharmacokinetic (PK) of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib (NCT01844583) | Millennium Pharmaceuticals, Inc. | 2013-06-25 |
| Gene Therapy for X-linked Chronic Granulomatous Disease (X-CGD) (NCT01855685) | Genethon | 2013-06-24 |
| Gene Therapy for X-linked Chronic Granulomatous Disease (NCT02757911) | Genethon | 2013-06-24 |
| NIR-Guided Sentinel Lymph-Node Mapping for Esophageal Cancer (NCT01808417) | Dana-Farber Cancer Institute | 2013-06-21 |
| A Dose-Escalation Study of GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors (NCT01875705) | Genentech, Inc. | 2013-06-21 |
| Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV) (NCT01860417) | Red de Terapia Celular | 2013-06-21 |
| Cabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus (NCT01822522) | National Cancer Institute (NCI) | 2013-06-21 |
| Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases (NCT01852370) | Paul Szabolcs | 2013-06-20 |
| A Clinical Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of Cebranopadol (NCT03882762) | Tris Pharma, Inc. | 2013-06-20 |
| A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment (NCT01801111) | Hoffmann-La Roche | 2013-06-20 |
| Pharmacokinetic Interaction of Darapladib and CYP 3A4 in Healthy Subjects (NCT01873339) | GlaxoSmithKline | 2013-06-19 |
| Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC (NCT01761240) | Morphotek | 2013-06-19 |
| The Interaction of Two HIV Medications With Blood Clot Medications in Healthy Volunteers (NCT01896622) | National Institutes of Health Clinical Center (CC) | 2013-06-18 |
| Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults (NCT02109354) | HIV Vaccine Trials Network | 2013-06-18 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863 (NCT01831804) | GlaxoSmithKline | 2013-06-17 |
| Phase I Trial of VS-6766 Alone and in Combination With Everolimus (NCT02407509) | Royal Marsden NHS Foundation Trust | 2013-06-17 |
| A First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single & Repeat Escalating Doses of GSK2878175 in Healthy Subjects (NCT01879462) | GlaxoSmithKline | 2013-06-14 |
| Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis (NCT01856634) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2013-06-14 |
| Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL (NCT01897571) | Epizyme, Inc. | 2013-06-13 |
| Antibody Treatment for Advanced Celiac Disease (NCT01893775) | National Cancer Institute (NCI) | 2013-06-12 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Retosiban (GSK221149) When Dosed With Efavirenz (EFZ) (NCT01867996) | GlaxoSmithKline | 2013-06-11 |
| NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors (NCT01875601) | National Cancer Institute (NCI) | 2013-06-11 |
| CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL) (NCT01653717) | M.D. Anderson Cancer Center | 2013-06-11 |
| Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies (NCT01823198) | M.D. Anderson Cancer Center | 2013-06-11 |
| Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid Tumors (NCT01862328) | Millennium Pharmaceuticals, Inc. | 2013-06-10 |
| Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis (NCT01799538) | National Heart, Lung, and Blood Institute (NHLBI) | 2013-06-10 |
| Kisspeptin in the Evaluation of Delayed Puberty (NCT01438034) | Massachusetts General Hospital | 2013-06-08 |
| A Study Evaluating the Safety and Efficacy of LentiGlobin BB305 Drug Product in β-Thalassemia Major (Also Referred to as Transfusion-dependent β-Thalassemia [TDT]) and Sickle Cell Disease (NCT02151526) | Genetix Biotherapeutics Inc. | 2013-06-07 |
| Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate (NCT02064036) | University of California, Davis | 2013-06-06 |
| Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC (NCT01783197) | Canadian Cancer Trials Group | 2013-06-04 |
| Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma (NCT01842308) | Mayo Clinic | 2013-06-04 |
| CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant (NCT02061800) | Diane George | 2013-06-03 |
| Mucinex® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4h (NCT03642262) | Reckitt Benckiser Inc. | 2013-06-02 |
| A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc (NCT01894776) | Ottawa Hospital Research Institute | 2013-06-01 |
| A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO5545965 in Healthy Volunteers (NCT01864226) | Hoffmann-La Roche | 2013-06-01 |
| Allogeneic Umbilical Cord Blood Therapy for Stroke (NCT01884155) | MinYoung Kim, M.D. | 2013-06-01 |
| Repeatability and Response Study of Absorptive Clearance Scans (NCT01887197) | Tim Corcoran | 2013-06-01 |
| The Treatment With HBIG+GM-CSF+HBV Vaccine for Chronic Hepatitis B Patients With HBeAg Seroconversion (NCT01878565) | Beijing 302 Hospital | 2013-06-01 |
| Phase 1, QT/QTC Interval Study in Healthy Subjects (NCT01910415) | Vertex Pharmaceuticals Incorporated | 2013-06-01 |
| Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile (NCT01744730) | Phillip Brian Smith | 2013-06-01 |
| Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma (NCT01863108) | University Hospital, Grenoble | 2013-06-01 |
| Magnetic Marker Monitoring of Furosemide-containing Gastroretentive Formulation in Healthy Male Subjects (Fasting and Fed Conditions) (NCT01887379) | LTS Lohmann Therapie-Systeme AG | 2013-06-01 |
| A Phase I- Sequential Cohort Dosing to Determine Maximum Tolerated Dose in Healthy Male Volunteers. (NCT01955564) | Newron Pharmaceuticals SPA | 2013-06-01 |
| A Study of LY2605541 in Healthy Participants (NCT01877265) | Eli Lilly and Company | 2013-06-01 |
| DCs Vaccine Combined With Cytokine-induced Killer Cells in Patients With AML (NCT01898663) | Affiliated Hospital to Academy of Military Medical Sciences | 2013-06-01 |
| Botulinum Toxin Injection Prevent Paroxysmal Atrial Fibrillation (NCT02002988) | Meshalkin Research Institute of Pathology of Circulation | 2013-06-01 |
| Phase 1 Single Dose Study of ALXN1101 in Healthy Volunteers (NCT01894165) | Origin Biosciences | 2013-06-01 |
| Study of Lumacaftor in Combination With Ivacaftor in Subjects With Moderate Hepatic Impairment and Healthy Subjects (NCT01888393) | Vertex Pharmaceuticals Incorporated | 2013-06-01 |
| Phase Ib Study of LDK378 and AUY922 in ALK-rearranged Non-small Cell Lung Cancer (NCT01772797) | Novartis Pharmaceuticals | 2013-06-01 |
| Peyronie's Disease Treatment Protocol (NCT02072018) | Hybrid Medical | 2013-06-01 |
| Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors (NCT01859858) | UNC Lineberger Comprehensive Cancer Center | 2013-06-01 |
| A Bioequivalence Study of Norgestimate /Ethinyl Estradiol (NGM/EE) Tablets Manufactured at 2 Different Facilities (NCT02127593) | Janssen Research & Development, LLC | 2013-06-01 |
| A Study Comparing the Effect of Amorphous Calcium Carbonate (ACC) on Healing Time of Distal Radius Fractures (NCT01859468) | Amorphical Ltd. | 2013-06-01 |
| Use of Ravicti™ in Patients With MCAD Deficiency With the 985A>G (K304E) Mutation (NCT01881984) | University of Pittsburgh | 2013-06-01 |
| First-in-Human Single and Multiple Dose of GLPG1205 (NCT01887106) | Lakefront Biotherapeutics NV | 2013-06-01 |
| Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22 (NCT01884740) | Weill Medical College of Cornell University | 2013-06-01 |
| Efficacy, Safety Study and Benefit of Alkali Therapy in Sickle Cell Disease (NCT01894594) | University Hospitals Cleveland Medical Center | 2013-06-01 |
| Study to Assess the Safety and Tolerability of Ascending Single Doses of REGN2009 in Healthy Volunteers (NCT01893528) | Regeneron Pharmaceuticals | 2013-06-01 |
| Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells for the Induction of Remission in Ulcerative Colitis (NCT01914887) | Instituto de Investigación Hospital Universitario La Paz | 2013-06-01 |
| The Effect of Ablation of Epidermal Nerve Fibers Using Capsaicin Cream (NCT01883102) | Mayo Clinic | 2013-06-01 |
| Intracoronary Transplantation of Bone Marrow Derived Mononuclear Cells in Pediatric Cardiomyopathy (NCT02256501) | Nasser Aghdami MD., PhD | 2013-06-01 |
| Autologous Adipose Tissue Stromal Vascular Fraction Cells for Rheumatoid Arthritis (NCT01885819) | Translational Biosciences | 2013-06-01 |